Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0771ae88b2a6d09ee67adcaa5a65c4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ec86d1bddeaf80d06715642801e91a8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y401-01033 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P5-026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y401-01033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C11-09 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C11-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P5-02 |
filingDate |
2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5b3422d1e131f89419088b14d750200 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d25e9e55829561cea2032dc8067325a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c302f3ca3016412cc88b6512036157 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00855c98a439011eca7ff4be40a37305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67290dfa9869578f3a2d09cf07333911 |
publicationDate |
2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018223266-A1 |
titleOfInvention |
Hiv kinase variants |
abstract |
Described are HIV kinase variants showing an improved activity in converting 3-hydroxyisovalerate (HIV) into 3-phosphonoxyisovalerate (PIV), methods for the production of PIV using such enzyme variants as well as methods for the production isobutene in a subsequent reaction. |
priorityDate |
2015-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |